As expected, Ven activated caspase-3, poly ADP-ribose polymerase 1 (PARP1), and GSDME in a concentration-dependent manner in Molm-13 and THP-1 cells as well as in primary cells from AML patients (Fig. 1G). This evidence concerns the gene PARP1 and acute myeloid leukemia.